Morningstar Investment Management LLC purchased a new position in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 3,467 shares of the company's stock, valued at approximately $552,000.
A number of other institutional investors also recently modified their holdings of the business. MOKAN Wealth Management Inc. raised its stake in Procter & Gamble by 13.7% during the second quarter. MOKAN Wealth Management Inc. now owns 15,319 shares of the company's stock worth $2,442,000 after acquiring an additional 1,846 shares in the last quarter. Benjamin Edwards Inc. increased its position in Procter & Gamble by 120.7% during the 1st quarter. Benjamin Edwards Inc. now owns 364,378 shares of the company's stock worth $62,098,000 after purchasing an additional 199,258 shares in the last quarter. Capital Investment Advisory Services LLC increased its holdings in shares of Procter & Gamble by 13.8% during the first quarter. Capital Investment Advisory Services LLC now owns 37,709 shares of the company's stock worth $6,426,000 after buying an additional 4,562 shares in the last quarter. World Investment Advisors increased its holdings in shares of Procter & Gamble by 6.0% during the first quarter. World Investment Advisors now owns 50,913 shares of the company's stock worth $8,677,000 after buying an additional 2,886 shares in the last quarter. Finally, Concurrent Investment Advisors LLC increased its holdings in Procter & Gamble by 26.4% in the 1st quarter. Concurrent Investment Advisors LLC now owns 120,002 shares of the company's stock worth $20,451,000 after purchasing an additional 25,059 shares in the last quarter. Institutional investors and hedge funds own 65.77% of the company's stock.
Procter & Gamble Stock Performance
Shares of Procter & Gamble stock opened at $147.54 on Tuesday. The business has a 50-day moving average price of $155.18 and a two-hundred day moving average price of $159.27. Procter & Gamble Company has a 1-year low of $146.96 and a 1-year high of $180.43. The company has a market cap of $345.32 billion, a P/E ratio of 22.66, a PEG ratio of 3.97 and a beta of 0.36. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49.
Procter & Gamble (NYSE:PG - Get Free Report) last posted its quarterly earnings results on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, topping analysts' consensus estimates of $1.42 by $0.06. The business had revenue of $20.89 billion during the quarter, compared to analysts' expectations of $20.79 billion. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The business's quarterly revenue was up 1.7% on a year-over-year basis. During the same period last year, the company posted $1.40 earnings per share. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. As a group, analysts anticipate that Procter & Gamble Company will post 6.91 EPS for the current year.
Insider Buying and Selling at Procter & Gamble
In related news, COO Shailesh Jejurikar sold 13,039 shares of Procter & Gamble stock in a transaction that occurred on Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $2,050,643.53. Following the transaction, the chief operating officer owned 28,036 shares of the company's stock, valued at $4,409,221.72. The trade was a 31.74% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Gary A. Coombe sold 10,194 shares of the business's stock in a transaction that occurred on Thursday, August 21st. The stock was sold at an average price of $158.16, for a total value of $1,612,283.04. Following the completion of the transaction, the chief executive officer owned 34,978 shares in the company, valued at $5,532,120.48. The trade was a 22.57% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 149,763 shares of company stock worth $23,421,279. 0.20% of the stock is currently owned by corporate insiders.
Wall Street Analyst Weigh In
Several equities analysts have issued reports on PG shares. Wells Fargo & Company decreased their price target on shares of Procter & Gamble from $173.00 to $170.00 and set an "overweight" rating for the company in a research report on Thursday, September 25th. JPMorgan Chase & Co. decreased their price objective on Procter & Gamble from $170.00 to $163.00 and set a "neutral" rating for the company in a report on Friday. Weiss Ratings reissued a "hold (c+)" rating on shares of Procter & Gamble in a research note on Wednesday, October 8th. Barclays decreased their price target on Procter & Gamble from $164.00 to $153.00 and set an "equal weight" rating for the company in a research note on Wednesday, October 1st. Finally, UBS Group decreased their price target on Procter & Gamble from $180.00 to $176.00 and set a "buy" rating for the company in a research note on Wednesday, October 8th. Eleven equities research analysts have rated the stock with a Buy rating and nine have issued a Hold rating to the company. According to data from MarketBeat.com, Procter & Gamble presently has an average rating of "Moderate Buy" and an average price target of $172.21.
Read Our Latest Analysis on Procter & Gamble
Procter & Gamble Company Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Articles
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.